Novel Aspects of Hepatic Mitochondrial Amino Acid Metabolism

肝线粒体氨基酸代谢的新方面

基本信息

  • 批准号:
    9789259
  • 负责人:
  • 金额:
    $ 38.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-22 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The production of glucose by the liver is a vital physiological process. Hepatic glucose production plays an important role in regulating normoglycemia during starvation, providing skeletal muscle with glucose during exercise, and contributing to hyperglycemia of diabetes. Gluconeogenesis, the process of converting the carbon in pyruvate, lactate, or amino acids into new glucose, plays an important role in glucose production by the liver. Gluconeogenesis requires the transport of pyruvate or amino acids across the impermeable inner mitochondrial membrane (IMM) and subsequent metabolism by enzymes exclusively localized to the mitochondrial matrix. Recent work from the laboratory of the applicant has demonstrated an important role for the mitochondrial pyruvate carrier (MPC) complex in gluconeogenesis from pyruvate/lactate. However, these studies also suggested an important role for pyruvate-alanine cycling as a compensatory mechanism when MPC activity was impaired. In addition, while amino acids like alanine are believed to be an important substrate for gluconeogenesis, many details regarding their metabolism are lacking. The significance of the proposed studies is that we will dissect the molecular mechanisms that mediate these processes in fasting, exercise, and diabetes. We hypothesize that the transcription factor ATF4 will regulate the expression of alanine transaminase 2 (ALT2) and that this enzyme will play an important role in regulating alanine-stimulated gluconeogenesis in diabetic liver (Specific Aim 1). We also hypothesize that that the effects of ALT2 deficiency on glucose production will be enhanced by concomitant loss of MPC activity to disrupt gluconeogenesis from both alanine and pyruvate. (Specific Aim 2). We also propose a third, exploratory Aim that has the potential for marked scientific advance. The transport of alanine across the impermeable IMM by a carrier-mediated process is required for alanine to be used for gluconeogenesis. However, the identity of the carrier that mediates this process has never been determined. We hypothesize that the yeast Avt5 and its mammalian homolog Slc38a10 serve as the mitochondrial alanine carrier and that these proteins are required for mitochondrial alanine metabolism (Specific Aim 3). We believe that the proposed studies will provide marked scientific advance towards our understanding of hepatic amino acid metabolism, which has been understudied to this point. In addition, these studies will provide insight into the effects of these metabolic pathways on hepatic gluconeogenesis and could impact pharmaceutical development of new drugs to treat diabetes.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian N Finck其他文献

Brian N Finck的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian N Finck', 18)}}的其他基金

Phenomaster NG Mouse Metabolic Phenotyping System
Phenomaster NG 小鼠代谢表型系统
  • 批准号:
    10427654
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Novel insulin-sensitizing NASH/diabetes drugs.
新型胰岛素增敏 NASH/糖尿病药物。
  • 批准号:
    10218153
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Novel insulin-sensitizing NASH/diabetes drugs.
新型胰岛素增敏 NASH/糖尿病药物。
  • 批准号:
    10096091
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Novel insulin-sensitizing NASH/diabetes drugs.
新型胰岛素增敏 NASH/糖尿病药物。
  • 批准号:
    10471836
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Novel Aspects of Hepatic Mitochondrial Amino Acid Metabolism
肝线粒体氨基酸代谢的新方面
  • 批准号:
    10170348
  • 财政年份:
    2018
  • 资助金额:
    $ 38.13万
  • 项目类别:
Novel Aspects of Hepatic Mitochondrial Amino Acid Metabolism
肝线粒体氨基酸代谢的新方面
  • 批准号:
    10406922
  • 财政年份:
    2018
  • 资助金额:
    $ 38.13万
  • 项目类别:
Targeting the mitochondrial pyruvate carrier to treat insulin resistance and nonalcoholic fatty liver disease
靶向线粒体丙酮酸载体治疗胰岛素抵抗和非酒精性脂肪肝
  • 批准号:
    10333375
  • 财政年份:
    2015
  • 资助金额:
    $ 38.13万
  • 项目类别:
Targeting the mitochondrial pyruvate carrier to treat insulin resistance and nonalcoholic fatty liver disease
靶向线粒体丙酮酸载体治疗胰岛素抵抗和非酒精性脂肪肝
  • 批准号:
    10533376
  • 财政年份:
    2015
  • 资助金额:
    $ 38.13万
  • 项目类别:
LIPIN 1 AND CARDIAC METABOLISM IN THE CONTEXT OF LIPID OVERLOAD
脂质超载背景下的 LIPIN 1 和心脏代谢
  • 批准号:
    8696255
  • 财政年份:
    2014
  • 资助金额:
    $ 38.13万
  • 项目类别:
LIPIN 1 AND CARDIAC METABOLISM IN THE CONTEXT OF LIPID OVERLOAD
脂质超载背景下的 LIPIN 1 和心脏代谢
  • 批准号:
    9304271
  • 财政年份:
    2014
  • 资助金额:
    $ 38.13万
  • 项目类别:

相似海外基金

Biosynthesis of bet-alanine in autolysosomes.
自溶酶体中 β-丙氨酸的生物合成。
  • 批准号:
    22K08681
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the metabolic consequences of the systemic alanine depletion in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中全身丙氨酸消耗的代谢后果
  • 批准号:
    474506
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Studentship Programs
Characterizing alanine transporters as therapeutic targets for pancreatic cancer
将丙氨酸转运蛋白描述为胰腺癌的治疗靶点
  • 批准号:
    466496
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Studentship Programs
Understanding the requirements of alanine supply and demand in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中丙氨酸的供需要求
  • 批准号:
    451838
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Operating Grants
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10230924
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10399593
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10570987
  • 财政年份:
    2021
  • 资助金额:
    $ 38.13万
  • 项目类别:
Spot measurement of alanine radicals produced by irradiation and application of sugar radial to dosimeter
辐照产生的丙氨酸自由基的点测及糖自由基在剂量计中的应用
  • 批准号:
    19K05343
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic significance of lysosomal beta-alanine
溶酶体β-丙氨酸的代谢意义
  • 批准号:
    18K08528
  • 财政年份:
    2018
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of dosimetry technique for IMRT using alanine dosimeter
使用丙氨酸剂量计开发 IMRT 剂量测定技术
  • 批准号:
    18K15615
  • 财政年份:
    2018
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了